PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Aventria Health Group as a Pharma Choice winner in the Variety category.
To support efforts to improve the quality of care of multiple myeloma patients at the point of care, Aventria created Vital Square™. Vital Square is a market access patient engagement platform that can be embedded into the case manager workflow and accessed via a laptop, iPad, or mobile phone to disseminate evidence-based, CMS-compliant educational resources.
Since 2009, the PM360 Pharma Choice awards has served as the only industry awards to recognize outstanding achievement and creativity in health care marketing by allowing the industry to choose the winners. All submissions are placed online where anyone in the industry can vote for their favorites based on content, format, imagination, influence on the industry, and overall quality. More than 7000 votes total were cast to decide this year’s winners.
In total, 45 winners were named in 15 distinct categories. The winning work is featured in the January/February 2020 issue of PM360. And can be viewed online at www.pm360online.com/2019-pm360-pharma-choice-award-winners.
For information about how Aventria Health Group can help you achieve market-access success, please reach out to:
Dave Dierk, Co-President, 30-year sales and marketing thought leader in pharmaceutical diagnostics, biomedical, long-term care, managed care, employer, and pharmacy communications, at 215-489-9000 x103 or email@example.com.
Making a difference in patient care by helping patients, providers, and payers collaborate on shared priorities